Literature DB >> 18571442

Serum protein signatures detect early radiographic osteoarthritis.

S M Ling1, D D Patel, P Garnero, M Zhan, M Vaduganathan, D Muller, D Taub, J M Bathon, M Hochberg, D R Abernethy, E J Metter, L Ferrucci.   

Abstract

OBJECTIVE: To test the hypothesis that early knee and hand osteoarthritis (OA) development is characterized by detectable changes in serum proteins relevant to inflammation, cell growth, activation, and metabolism several years before OA becomes radiographically evident.
METHODS: Using microarray platforms that simultaneously test 169 proteins relevant to inflammation, cell growth, activation and metabolism, we conducted a case-control study nested within the Baltimore Longitudinal Study of Aging (BLSA). Subjects included 22 incident cases of OA and 66 age-, sex- and body mass index (BMI)-matched controls. Serum samples tested were obtained at the time of radiographic classification as either case or control, and up to 10 years earlier at a time when all participants were free of radiographic OA. Proteins with mean signal intensities fourfold higher than background were compared between cases and controls using multivariate techniques.
RESULTS: Sixteen proteins were different between OA cases compared to controls. Four of these proteins [matrix metalloproteinase (MMP)-7, interleukin (IL)-15, plasminogen activator inhibitor (PAI)-1 and soluble vascular adhesion protein (sVAP)-1] were already different in samples obtained 10 years before radiographic classification and remained different at the time of diagnosis. Six additional proteins were only associated with subsequent OA development and not with established OA.
CONCLUSIONS: Changes in serum proteins implicated in matrix degradation, cell activation, inflammation and bone collagen degradation products accompany early OA development and can precede radiographic detection by several years.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18571442      PMCID: PMC2667202          DOI: 10.1016/j.joca.2008.05.004

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  24 in total

1.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.

Authors:  Y Yoshihara; H Nakamura; K Obata; H Yamada; T Hayakawa; K Fujikawa; Y Okada
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

Review 2.  State-of-the-art disease-modifying osteoarthritis drugs.

Authors:  Roland W Moskowitz; Michele Hooper
Journal:  Curr Rheumatol Rep       Date:  2005-03       Impact factor: 4.592

Review 3.  Biomarkers in osteoarthritis.

Authors:  Virginia Byers Kraus
Journal:  Curr Opin Rheumatol       Date:  2005-09       Impact factor: 5.006

4.  Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.

Authors:  Nadine Charni; Fabrice Juillet; Patrick Garnero
Journal:  Arthritis Rheum       Date:  2005-04

5.  Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study.

Authors:  Bo Baslund; Niels Tvede; Bente Danneskiold-Samsoe; Per Larsson; Gabriel Panayi; Joergen Petersen; Lars J Petersen; Frank J M Beurskens; Janine Schuurman; Jan G J van de Winkel; Paul W H I Parren; J Alastair Gracie; Sarah Jongbloed; Foo Y Liew; Iain B McInnes
Journal:  Arthritis Rheum       Date:  2005-09

6.  Clusters of biochemical markers are associated with radiographic subtypes of osteoarthritis (OA) in subject with familial OA at multiple sites. The GARP study.

Authors:  I Meulenbelt; M Kloppenburg; H M Kroon; J J Houwing-Duistermaat; P Garnero; M-P Hellio-Le Graverand; J DeGroot; P E Slagboom
Journal:  Osteoarthritis Cartilage       Date:  2006-10-17       Impact factor: 6.576

7.  Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort.

Authors:  Patrick Garnero; Bernard Mazières; Alice Guéguen; Michel Abbal; Laurent Berdah; Michel Lequesne; Minh Nguyen; Jean-Pierre Salles; Eric Vignon; Maxime Dougados
Journal:  J Rheumatol       Date:  2005-04       Impact factor: 4.666

8.  Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.

Authors:  L S Lohmander; M Ionescu; H Jugessur; A R Poole
Journal:  Arthritis Rheum       Date:  1999-03

9.  Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis.

Authors:  C G Peterfy; A Guermazi; S Zaim; P F J Tirman; Y Miaux; D White; M Kothari; Y Lu; K Fye; S Zhao; H K Genant
Journal:  Osteoarthritis Cartilage       Date:  2004-03       Impact factor: 6.576

10.  Optimization of Rolling-Circle Amplified Protein Microarrays for Multiplexed Protein Profiling.

Authors:  Weiping Shao; Zhimin Zhou; Isabelle Laroche; Hong Lu; Qiuling Zong; Dhavalkumar D. Patel; Stephen Kingsmore; Steven P. Piccoli
Journal:  J Biomed Biotechnol       Date:  2003
View more
  25 in total

Review 1.  Osteoarthritis: a disease of the joint as an organ.

Authors:  Richard F Loeser; Steven R Goldring; Carla R Scanzello; Mary B Goldring
Journal:  Arthritis Rheum       Date:  2012-03-05

Review 2.  Targeting subchondral bone for treating osteoarthritis: what is the evidence?

Authors:  Steeve Kwan Tat; Daniel Lajeunesse; Jean-Pierre Pelletier; Johanne Martel-Pelletier
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-02       Impact factor: 4.098

Review 3.  Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use.

Authors:  V B Kraus; F J Blanco; M Englund; M A Karsdal; L S Lohmander
Journal:  Osteoarthritis Cartilage       Date:  2015-04-09       Impact factor: 6.576

4.  Minimally Invasive Approach for Diagnosing TMJ Osteoarthritis.

Authors:  B Shoukri; J C Prieto; A Ruellas; M Yatabe; J Sugai; M Styner; H Zhu; C Huang; B Paniagua; S Aronovich; L Ashman; E Benavides; P de Dumast; N T Ribera; C Mirabel; L Michoud; Z Allohaibi; M Ioshida; L Bittencourt; L Fattori; L R Gomes; L Cevidanes
Journal:  J Dent Res       Date:  2019-07-24       Impact factor: 6.116

Review 5.  Prognostic biomarkers in osteoarthritis.

Authors:  Mukundan Attur; Svetlana Krasnokutsky-Samuels; Jonathan Samuels; Steven B Abramson
Journal:  Curr Opin Rheumatol       Date:  2013-01       Impact factor: 5.006

6.  Pathologic and pathogenic processes in osteoarthritis: the effects of synovitis.

Authors:  Carla R Scanzello
Journal:  HSS J       Date:  2011-12-23

Review 7.  The role of synovitis in osteoarthritis pathogenesis.

Authors:  Carla R Scanzello; Steven R Goldring
Journal:  Bone       Date:  2012-02-22       Impact factor: 4.398

Review 8.  Cytokines as biochemical markers for knee osteoarthritis.

Authors:  Thomas Mabey; Sittisak Honsawek
Journal:  World J Orthop       Date:  2015-01-18

9.  Network medicine analysis of chondrocyte proteins towards new treatments of osteoarthritis.

Authors:  Jose C Nacher; Benjamin Keith; Jean-Marc Schwartz
Journal:  Proc Biol Sci       Date:  2014-01-15       Impact factor: 5.349

Review 10.  The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases.

Authors:  Cem Gabay; Iain B McInnes
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.